Treatment with lipoxin A4 improves influenza A infection outcome, induces macrophage reprogramming, anti-inflammatory and pro-resolutive responses

Related articles

1. Enhancement of anti-programmed cell death protein-1 immunotherapy in non-small cell lung cancer using arginine and citrulline supplementation

   This article has 7 authors:

   1. Naoki Miyamoto
   2. Mitsuteru Yoshida
   3. Shinichi Tsukumo
   4. Hirohisa Ogawa
   5. Tamaki Otani
   6. Koji Yasutomo
   7. Hiromitsu Takizawa

2. Rewired type I IFN signaling is linked to age-dependent differences in COVID-19

   This article has 32 authors:

   1. Lev Petrov
   2. Sophia Brumhard
   3. Sebastian Wisniewski
   4. Philipp Georg
   5. David Hillus
   6. Anna Hiller
   7. Rosario Astaburuaga-García
   8. Nils Blüthgen
   9. Emanuel Wyler
   10. Katrin Vogt
   11. Hannah-Philine Dey
   12. Saskia von Stillfried
   13. Christina Iwert
   14. Roman D. Bülow
   15. Bruno Märkl
   16. Lukas Maas
   17. Christine Langner
   18. Tim Meyer
   19. Jennifer Loske
   20. Roland Eils
   21. Irina Lehmann
   22. Benjamin Ondruschka
   23. Markus Ralser
   24. Jakob Trimpert
   25. Peter Boor
   26. Sammy Bedoui
   27. Christian Meisel
   28. Marcus A. Mall
   29. Victor M. Corman
   30. Leif Erik Sander
   31. Jobst Röhmel
   32. Birgit Sawitzki

3. Chronic ketosis provides neuroprotection through HIF-1α-mediated control of the TXNIP/NLRP3 axis by regulating the inflammatory and apoptotic response

   This article has 6 authors:

   1. Kehkashan Parveen
   2. Mohd Salman
   3. Golnoush Mirzahosseini PharmD
   4. Arshi Parveen
   5. Tauheed Ishrat
   6. Michelle A. Puchowicz